What does Sponsor Oversight really mean? -
How much is enough to meet the requirements?
Anna Asplind and Charlotta Björk, senior clinical project managers at PharmaRelations, take us on a journey through the area based on their experiences in Sponsor Oversight.
We have chosen to dive deep into the sponsor oversight area to increase knowledge and clarity in what is required of the companies when they choose to outsource the entire study to a CRO company. We will give examples of the most critical areas and their pitfalls.
This webinar is part 1 of a series of webinars on Sponsor oversight. In part 1, we will give you an overview of Sponsor oversight and during the autumn we will dive deeper into the different parts.
|Anna and Charlotta have extensive experience as clinical project managers within clinical trials, both from small start-ups, biotech, and MedTech companies to medium-sized and large pharmaceutical companies, as well as CRO companies.|
Date: Thursday 8 September 2022
Time: 9:30 - 10:15 am (CEST)
Place: Webinar - You will receive a link to join
Scientific affairs focus on competencies in clinical studies. We will help you to get new drugs, products, methods, and devices to the market faster!
| visit pharmarelations.com|
PharmaRelations AB Frösundaviks Allé 1, Plan 6 | Box 4070 |169 04 Solna, Sweden +46 (0)8 590 745 81